These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 365599)

  • 1. Gonadotropin secretion in eugonadotropic human males and postmenopausal females under long-term application of a potent analog of gonadotropin-releasing hormone.
    Happ J; Scholz P; Weber T; Cordes U; Schramm P; Neubauer M; Beyer J
    Fertil Steril; 1978 Dec; 30(6):674-8. PubMed ID: 365599
    [No Abstract]   [Full Text] [Related]  

  • 2. Gonadotropin and testosterone secretion in normal human males after stimulation with gonadotropin-releasing hormone (GnRH) or potent GnRH analogs using different modes of application.
    Happ J; Hartmann U; Weber T; Cordes U; Beyer J
    Fertil Steril; 1978 Dec; 30(6):666-73. PubMed ID: 365598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
    Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
    J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short term administration of gonadotropin-releasing hormone analog to a patient with a testosterone-secreting ovarian tumor.
    Kennedy L; Traub AI; Atkinson AB; Sheridan B
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1320-2. PubMed ID: 3106399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged elevation of luteinizing hormone (LH) after intranasal administration of an analog of LH-releasing hormone.
    Gonzalez-Barcena D; Kastin AJ; Schalch DS; Coy DH; Schally AV
    Fertil Steril; 1976 Nov; 27(11):1246-9. PubMed ID: 789118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced gonadotropin secretion in postmenopausal women during treatment with a stimulatory LRH analogue.
    Bergquist C; Nillius SJ; Wide L
    J Clin Endocrinol Metab; 1979 Sep; 49(3):472-4. PubMed ID: 381324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic LH-releasing hormone (LH-RH) administered to normal men by different routes.
    Gonzalez-Barcena D; Kastin AJ; Schalch DS; Bermudez JA; Lee D; Arimura A; Ruelas J; Zepeda I; Schally AV
    J Clin Endocrinol Metab; 1973 Sep; 37(3):481-4. PubMed ID: 4594410
    [No Abstract]   [Full Text] [Related]  

  • 8. Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phase.
    Lemay A; Metha AE; Tolis G; Faure N; Labrie F; Fazekas AT
    Fertil Steril; 1983 May; 39(5):668-73. PubMed ID: 6404661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men.
    Pavlou SN; Debold CR; Island DP; Wakefield G; Rivier J; Vale W; Rabin D
    J Clin Endocrinol Metab; 1986 Aug; 63(2):303-8. PubMed ID: 3088019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive actions of a gonadotropin-releasing hormone antagonist on luteinizing hormone, follicle-stimulating hormone, and prolactin release in estrogen-deficient postmenopausal women.
    Urban RJ; Pavlou SN; Rivier JE; Vale WW; Dufau ML; Veldhuis JD
    Am J Obstet Gynecol; 1990 May; 162(5):1255-60. PubMed ID: 2111095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antireproductive effects of a potent gonadotropin-releasing hormone antagonist in the male rat.
    Rivier C; Rivier J; Vale W
    Science; 1980 Oct; 210(4465):93-5. PubMed ID: 6774418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma gonadotropin-releasing hormone profiles after intravenous and subcutaneous bolus injection in thin and obese women.
    Lyles R; Elkind-Hirsch K; Goldzieher JW; Besch PK
    Obstet Gynecol; 1988 Jan; 71(1):44-8. PubMed ID: 3122139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen selectively stimulates follicle-stimulating hormone-beta mRNA levels after gonadotropin-releasing hormone antagonist administration.
    Wierman ME; Wang C
    Biol Reprod; 1990 Mar; 42(3):563-71. PubMed ID: 2111188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-releasing hormone analog and testosterone synergistically inhibit spermatogenesis.
    Heber D; Swerdloff RS
    Endocrinology; 1981 May; 108(5):2019-21. PubMed ID: 6783399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal application of luteinising-hormone releasing hormone.
    Solbach HG; Wiegelman W
    Lancet; 1973 Jun; 1(7814):1259. PubMed ID: 4122614
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of pituitary response to nasal application of synthetic gonadotropin-releasing hormone in men.
    Potashnik G; Ben-Adereth N; Lunenfeld B; Rofe C
    Fertil Steril; 1977 Jun; 28(6):650-4. PubMed ID: 324823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous, intramuscular, subcutaneous and intranasal administration of LH-FSH-RH: the duration of effect and occurrence of asynchronous pulsatile release of LH and FSH.
    Mortimer CH; Besser GM; Hook J; McNeilly AS
    Clin Endocrinol (Oxf); 1974 Jan; 3(1):19-25. PubMed ID: 4600809
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of chronic treatment with an LHRH agonist on the secretion of LH, FSH and testosterone in the ram.
    Fraser HM; Lincoln GA
    Biol Reprod; 1980 Mar; 22(2):269-76. PubMed ID: 6769512
    [No Abstract]   [Full Text] [Related]  

  • 19. Male contraception; synergism of gonadotropin-releasing hormone analog and testosterone in suppressing gonadotropin.
    Heber D; Swerdloff RS
    Science; 1980 Aug; 209(4459):936-8. PubMed ID: 6773142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
    Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
    J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.